Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repeat Ivermectin MDA for Malaria Control
NCT02509481Phase 3Completed
- Sponsor
- Colorado State University
- Start
- Jun 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ivermectin in malaria, lymphatic filariasis (LF), sponsored by Colorado State University. Started Jun 2015; status: completed.
02
Drugs
ivermectin
03
Conditions
malarialymphatic filariasis (LF)
Beyond the preview
Go deeper on NCT02509481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02509481.